HeartSciences (HSCS) Receivables - Net (2022 - 2025)

HeartSciences' (HSCS) quarterly Receivables - Net came in at $4350.0 in Q4 2025, down 70.41% on a QoQ basis from $14700.0 in Q1 2024.

HeartSciences (HSCS) Receivables - Net (2022 - 2025) Analysis & Trends

HeartSciences (HSCS) has 4 years of Receivables - Net data on file, last reported at $4350.0 in Q4 2025.

Quarterly Receivables - Net changed N/A year-over-year to $4350.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4350.0 (changed N/A YoY) and the FY2025 annual result came in at $4350.0, changed N/A from the prior year.
Receivables - Net slipped to $4350.0 in Q4 2025, from $14700.0 in the prior quarter.
In the past five years, Receivables - Net ranged from a high of $14700.0 in Q1 2024 to a low of $2321.0 in Q2 2022.
A 4-year average of $6317.8 and a median of $4125.0 in 2023 frame the typical range for Receivables - Net.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	HeartSciences	6.54 Mn	4.84 Mn	-

Download Data